ANXA10 | Annexin A10 | Predicted intracellular proteins
| | | | | Tissue enriched |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AP3B2 | Adaptor-related protein complex 3, beta 2 subunit | Predicted intracellular proteins
| | | | | Tissue enriched |
APBA1 | Amyloid beta (A4) precursor protein-binding, family A, member 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APOA2 | Apolipoprotein A-II | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOBEC2 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 | Predicted intracellular proteins
| | | | | Group enriched |
APOC1 | Apolipoprotein C-I | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOH | Apolipoprotein H (beta-2-glycoprotein I) | Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
AQP10 | Aquaporin 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP12A | Aquaporin 12A | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP12B | Aquaporin 12B | Predicted membrane proteins
| | | | | Tissue enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Group enriched |
ARHGAP25 | Rho GTPase activating protein 25 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP28 | Rho GTPase activating protein 28 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP36 | Rho GTPase activating protein 36 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ARL9 | ADP-ribosylation factor-like 9 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARMC3 | Armadillo repeat containing 3 | Predicted intracellular proteins
| | | | | Group enriched |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ASAH2 | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ASAH2B | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B | Predicted intracellular proteins
| | | | | Group enriched |
ASB9 | Ankyrin repeat and SOCS box containing 9 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ASCL1 | Achaete-scute family bHLH transcription factor 1 | Predicted secreted proteins Transcription factors
| | | | | Tissue enriched |
ASGR1 | Asialoglycoprotein receptor 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
ASGR2 | Asialoglycoprotein receptor 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ASPA | Aspartoacylase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ASPRV1 | Aspartic peptidase, retroviral-like 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ASRGL1 | Asparaginase like 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ASZ1 | Ankyrin repeat, SAM and basic leucine zipper domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP4A | ATPase, H+/K+ exchanging, alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP4B | ATPase, H+/K+ exchanging, beta polypeptide | Predicted membrane proteins Transporters
| | | | | Tissue enriched |